Diagnostics
Thermally stable anti-caffeine heavy-chain antibody fragment is characterized
Published in Medical Letter on the CDC and FDA, September 3rd, 2006
"We have isolated and characterized a caffeine-specific, heavy-chain-only antibody fragment (VHH ) from llama that is capable of being utilized to analyze caffeine in hot and cold beverages," researchers in the United States report.
"Camelid species (llama and camel) were selected for immunization because of their potential to make heat-stable, heavy-chain-only antibodies," explained Ruth C. Ladenson and colleagues at Washington University. "Llamas and camels were immunized with caffeine covalently linked to keyhole...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Drug Safety
Many drug expiration dates can be extended beyond label value - Hepatitis C Virus
HAART in HIV/HCV-co-infected patients is linked to increase in hepatitis C virus titers - Monkeypox Diagnosis
Real-time PCR assays to detect monkeypox virus have been developed - Smallpox Vaccine
Contraindications keep public health workers from obtaining smallpox vaccination - Tuberculosis Diagnosis
Program identifies and treats tuberculosis at HIV counseling and testing center in Uganda - Addiction Medicine
Thienorphine is potent long-acting partial opioid agonist - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
